<DOC>
	<DOC>NCT01571063</DOC>
	<brief_summary>Test the efficacy of vitamin D to improve non-alcoholic steatohepatitis with regard to biochemical and histological parameters. - Trial with medicinal product</brief_summary>
	<brief_title>Treatment of Non-alcoholic Steatohepatitis (NASH) Patients With Vitamin D</brief_title>
	<detailed_description />
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Inclusion criteria: Patients with 25OH vitamin D insufficiency Elevated alanine aminotransferase level Diagnosis of definite or possible steatohepatitis (NASH) Exclusion criteria: Cirrhosis, present liver disease other than NASH Serious diseases limiting life expectancy, Breastfeeding or pregnant women Unhealthy alcohol consumption Drug abuse or substitution therapy Use of vitamin preparations within the previous 6 months and during the study Weight loss &gt;5% within 12 months before study entry Newly diagnosed Diabetes mellitus requiring medical treatment within 12 months before study entry Use of antiobesity drugs Previous or current hypercalcemia Chronic renal disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>